Education
About Us
Working with TipRanks
Follow Us
Amicus Therapeutics (GB:0HF9)
:0HF9
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 528.29M | $ 399.36M | $ 329.23M | $ 305.51M | $ 260.89M |
| Gross Profit | $ 475.35M | $ 362.03M | $ 290.63M | $ 271.05M | $ 229.84M |
| Operating Income | $ 24.88M | $ -73.49M | $ -204.43M | $ -199.92M | $ -243.85M |
| EBITDA | $ 29.39M | $ -92.08M | $ -199.58M | $ -202.87M | $ -242.98M |
| Net Income | $ -56.11M | $ -151.58M | $ -236.57M | $ -250.46M | $ -276.85M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 249.95M | $ 286.20M | $ 293.60M | $ 482.50M | $ 483.27M |
| Total Assets | $ 785.03M | $ 777.88M | $ 724.17M | $ 905.14M | $ 886.52M |
| Total Debt | $ 443.64M | $ 445.06M | $ 452.12M | $ 440.13M | $ 441.73M |
| Net Debt | $ 229.89M | $ 198.06M | $ 303.31M | $ 194.93M | $ 278.49M |
| Total Liabilities | $ 590.99M | $ 617.71M | $ 601.12M | $ 597.77M | $ 600.14M |
| Stockholders' Equity | $ 194.04M | $ 160.17M | $ 123.05M | $ 307.37M | $ 286.38M |
| Cash Flow | |||||
| Free Cash Flow | $ -37.44M | $ -76.53M | $ -170.34M | $ -206.38M | $ -236.52M |
| Operating Cash Flow | $ -33.89M | $ -69.09M | $ -166.57M | $ -202.49M | $ -233.29M |
| Investing Cash Flow | $ -560.00K | $ 98.06M | $ 92.32M | $ 78.76M | $ -13.58M |
| Financing Cash Flow | $ 5.12M | $ 61.68M | $ -7.46M | $ 212.07M | $ 262.86M |